Merck & Co. Wins U.S. Approval for Melanoma Immunotherapy (1)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers MRK US (Merck & Co Inc) 3400398Z US (HHS Food & Drug Administration)
People Kenneth Frazier (Merck & Co Inc)
Topics Cancers Skin Cancer, Melanoma Lung Cancer
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283